Serial BMD test not beneficial for Identifying Hip Fracture risk: JAMA
According to a recent study, a second bone mineral density (BMD) assessment about three years after initial measurement does not improve discrimination beyond baseline BMD value alone for women who do and do not experience a subsequent hip fracture or major osteoporotic fracture.
Researchers have published their findings in JAMA Internal Medicine.
Carolyn J. Crandall and colleagues, from the University of California in Los Angeles, examined whether a second BMD measurement about three years after the initial assessment is associated with improved ability to estimate fracture risk.
This cohort study included 7,419 women from the Women's Health Initiative, with a mean follow-up of 12.1 years between 1993 and 2010. Data analysis for this observational study was conducted between May 2019 and December 2019. The main parameters that were assessed were major osteoporotic fracture (i.e., hip, clinical spine, forearm, or shoulder fracture), hip fracture, baseline BMD, and absolute change in BMD.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.